Literature DB >> 2434816

Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy.

B J Thomson, M Doran, A M Lever, A D Webster.   

Abstract

Three hypogammaglobulinaemic patients with non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy were treated with lymphoblastoid alpha-interferon. All showed a striking improvement in serum aminotransferases after the start of each course of treatment.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2434816     DOI： 10.1016/s0140-6736(87)90178-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  16 in total

1.  Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes.

Authors:  T Okuno; M Shindo; K Arai; M Matsumoto; M Takeda
Journal:  Gastroenterol Jpn       Date:  1990-02

Review 2.  Parenterally acquired non-A non-B hepatitis ten years on: advances in diagnosis and therapy.

Authors:  M R Jacyna; H C Thomas
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 3.  [Therapy of hepatitis C].

Authors:  D M Alscher; J C Bode
Journal:  Med Klin (Munich)       Date:  1997-03-15

Review 4.  Interferon for treatment: the dust settles.

Authors:  D Galvani; S D Griffiths; J C Cawley
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-04

5.  Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.

Authors:  D D Douglas; J Rakela; H J Lin; F B Hollinger; H F Taswell; A J Czaja; J B Gross; M L Anderson; K Parent; C R Fleming
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

6.  Initial results with recombinant interferon alfa-2b in patients with chronic hepatitis C: the United States experience.

Authors:  G L Davis
Journal:  Gut       Date:  1993       Impact factor: 23.059

7.  Hepatocyte regeneration in chronic hepatitis C and interferon treatment: analysis of immunohistological identification of proliferating cell nuclear antigen (PCNA).

Authors:  M Hamada; T Kihira; K Takase; T Nakano; Y Tameda; Y Kosaka
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

8.  Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.

Authors:  R Wejstål; G Norkrans; O Weiland; R Schvarcz; D Fuchs; H Wachter; A Fryden; H Glaumann
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

9.  Alanine aminotransferase and HCV-RNA responses following interferon therapy of HCV-RNA positive chronic hepatitis.

Authors:  Y Arase; H Kumada; K Chayama; A Tsubota; K Ikeda; S Saitoh; Y Sakai; T Matsumoto; M Kobayashi
Journal:  Gastroenterol Jpn       Date:  1992-10

10.  Sustained virologic response following HCV eradication in two brothers with X-linked agammaglobulinaemia.

Authors:  Diarmaid D Houlihan; Eoin R Storan; John M Lee
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.